Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tgif1
|
ENSMUSG00000047407.11 | TGFB-induced factor homeobox 1 |
Meis3
|
ENSMUSG00000041420.12 | Meis homeobox 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_16155636_16155787 | Meis3 | 19379 | 0.101936 | 0.59 | 2.5e-06 | Click! |
chr7_16192500_16192651 | Meis3 | 8485 | 0.110802 | 0.42 | 1.3e-03 | Click! |
chr7_16156243_16156394 | Meis3 | 18772 | 0.102843 | 0.42 | 1.4e-03 | Click! |
chr7_16187632_16187783 | Meis3 | 3617 | 0.141583 | 0.25 | 6.2e-02 | Click! |
chr7_16153518_16153800 | Meis3 | 21431 | 0.098805 | 0.22 | 1.1e-01 | Click! |
chr17_70845925_70846296 | Tgif1 | 216 | 0.876545 | -0.62 | 5.7e-07 | Click! |
chr17_70845241_70845426 | Tgif1 | 993 | 0.370763 | -0.59 | 1.8e-06 | Click! |
chr17_70848812_70849474 | Tgif1 | 501 | 0.647420 | -0.56 | 7.4e-06 | Click! |
chr17_70849476_70849724 | Tgif1 | 44 | 0.950867 | -0.54 | 1.7e-05 | Click! |
chr17_70849727_70850029 | Tgif1 | 64 | 0.946541 | -0.54 | 2.3e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_65961618_65962124 | 48.01 |
Ankrd12 |
ankyrin repeat domain 12 |
10521 |
0.14 |
chr12_28055447_28056122 | 17.49 |
Gm25923 |
predicted gene, 25923 |
4744 |
0.29 |
chr16_3238621_3239720 | 17.07 |
Gm23215 |
predicted gene, 23215 |
10414 |
0.18 |
chr1_151801648_151802002 | 16.13 |
Edem3 |
ER degradation enhancer, mannosidase alpha-like 3 |
46365 |
0.12 |
chr4_49041678_49042070 | 15.66 |
Plppr1 |
phospholipid phosphatase related 1 |
17399 |
0.23 |
chr2_34904909_34905764 | 15.59 |
Phf19 |
PHD finger protein 19 |
429 |
0.72 |
chr8_48376860_48377086 | 15.14 |
Tenm3 |
teneurin transmembrane protein 3 |
76874 |
0.11 |
chr13_12133466_12133831 | 14.92 |
Ryr2 |
ryanodine receptor 2, cardiac |
26703 |
0.13 |
chr6_33947005_33947225 | 13.96 |
Gm13853 |
predicted gene 13853 |
45296 |
0.16 |
chr3_156947544_156947739 | 13.87 |
Gm15577 |
predicted gene 15577 |
26861 |
0.2 |
chr18_80330855_80331538 | 13.45 |
Gm26676 |
predicted gene, 26676 |
7861 |
0.14 |
chr2_26594675_26595827 | 13.36 |
Egfl7 |
EGF-like domain 7 |
3104 |
0.11 |
chr12_29663403_29663734 | 13.31 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
22877 |
0.25 |
chr3_95228479_95230526 | 13.22 |
Cdc42se1 |
CDC42 small effector 1 |
550 |
0.43 |
chr5_97415807_97416224 | 13.19 |
4930467D21Rik |
RIKEN cDNA 4930467D21 gene |
23568 |
0.17 |
chr16_33605736_33606716 | 12.93 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr3_86786918_86787697 | 12.91 |
Dclk2 |
doublecortin-like kinase 2 |
5008 |
0.21 |
chr1_165110712_165111050 | 12.86 |
4930568G15Rik |
RIKEN cDNA 4930568G15 gene |
18953 |
0.15 |
chr10_3417310_3417750 | 12.78 |
Gm24482 |
predicted gene, 24482 |
7493 |
0.25 |
chr16_33606719_33607344 | 12.64 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9359 |
0.26 |
chr3_134339308_134339650 | 12.28 |
Gm43558 |
predicted gene 43558 |
17813 |
0.17 |
chr13_104627594_104628041 | 12.25 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
57114 |
0.15 |
chr9_58815921_58816146 | 12.08 |
Hcn4 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 4 |
7379 |
0.24 |
chr5_141097981_141098158 | 12.03 |
Gm26113 |
predicted gene, 26113 |
17638 |
0.22 |
chr7_114311264_114311510 | 12.00 |
Psma1 |
proteasome subunit alpha 1 |
35269 |
0.17 |
chr13_49370675_49371884 | 11.94 |
Bicd2 |
BICD cargo adaptor 2 |
11810 |
0.19 |
chr11_38193862_38194036 | 11.66 |
Gm12129 |
predicted gene 12129 |
25120 |
0.27 |
chr12_3236518_3237725 | 11.66 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr11_4572974_4574056 | 11.54 |
Gm11960 |
predicted gene 11960 |
9883 |
0.16 |
chr10_111519699_111519862 | 11.25 |
Phlda1 |
pleckstrin homology like domain, family A, member 1 |
12084 |
0.13 |
chr19_27099817_27100328 | 11.02 |
Gm35438 |
predicted gene, 35438 |
2625 |
0.36 |
chr13_46571170_46571543 | 10.88 |
Cap2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
38158 |
0.13 |
chr1_41814359_41814918 | 10.60 |
Gm29260 |
predicted gene 29260 |
32830 |
0.25 |
chr10_86961941_86962146 | 10.59 |
Gm16271 |
predicted gene 16271 |
10173 |
0.15 |
chr16_5431217_5431559 | 10.51 |
n-R5s30 |
nuclear encoded rRNA 5S 30 |
107231 |
0.06 |
chr13_53099784_53100181 | 10.47 |
Gm48336 |
predicted gene, 48336 |
71064 |
0.1 |
chr17_6216648_6216812 | 10.47 |
Tulp4 |
tubby like protein 4 |
15922 |
0.14 |
chr6_113889602_113889753 | 10.46 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
1693 |
0.36 |
chr6_28705336_28705711 | 10.45 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
197 |
0.96 |
chr16_3235917_3236318 | 10.42 |
Gm23215 |
predicted gene, 23215 |
13467 |
0.17 |
chr11_107965416_107965870 | 10.39 |
Prkca |
protein kinase C, alpha |
13996 |
0.15 |
chr15_38342953_38343114 | 10.38 |
Gm35248 |
predicted gene, 35248 |
30740 |
0.12 |
chr4_126850161_126850502 | 10.28 |
AU040320 |
expressed sequence AU040320 |
186 |
0.92 |
chr17_27679167_27679824 | 10.24 |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
5686 |
0.12 |
chr3_58804748_58805067 | 10.21 |
Mindy4b-ps |
MINDY lysine 48 deubiquitinase 4B, pseudogene |
7036 |
0.21 |
chr17_71698269_71698678 | 10.17 |
Togaram2 |
TOG array regulator of axonemal microtubules 2 |
11772 |
0.12 |
chrX_130189358_130189529 | 10.15 |
Gm14984 |
predicted gene 14984 |
212776 |
0.02 |
chr2_137939077_137939470 | 9.93 |
Gm14062 |
predicted gene 14062 |
62442 |
0.16 |
chr13_24629399_24629595 | 9.92 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
9151 |
0.2 |
chr1_90504528_90505067 | 9.92 |
Gm35048 |
predicted gene, 35048 |
15699 |
0.22 |
chr10_42005361_42005525 | 9.80 |
Armc2 |
armadillo repeat containing 2 |
12277 |
0.19 |
chrX_6926230_6926408 | 9.78 |
Dgkk |
diacylglycerol kinase kappa |
52835 |
0.15 |
chr12_25293896_25294068 | 9.73 |
Gm36723 |
predicted gene, 36723 |
9958 |
0.18 |
chr1_132853424_132853608 | 9.69 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
26757 |
0.15 |
chr6_31835987_31836222 | 9.69 |
Gm13849 |
predicted gene 13849 |
49429 |
0.16 |
chr18_86601875_86602052 | 9.67 |
Gm50386 |
predicted gene, 50386 |
8 |
0.99 |
chr6_30572801_30573105 | 9.65 |
Gm13781 |
predicted gene 13781 |
3082 |
0.16 |
chr4_41612407_41612596 | 9.60 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
19143 |
0.1 |
chr3_135585290_135585641 | 9.57 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
8976 |
0.17 |
chr18_9491223_9491696 | 9.56 |
Gm7527 |
predicted gene 7527 |
4162 |
0.19 |
chr14_36651177_36651350 | 9.55 |
Gm17940 |
predicted gene, 17940 |
31985 |
0.19 |
chr2_181156387_181156681 | 9.55 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
480 |
0.69 |
chr1_41027544_41027944 | 9.48 |
4930448I06Rik |
RIKEN cDNA 4930448I06 gene |
153508 |
0.04 |
chr16_90449803_90450060 | 9.48 |
Hunk |
hormonally upregulated Neu-associated kinase |
11966 |
0.2 |
chr3_82274643_82274867 | 9.41 |
Map9 |
microtubule-associated protein 9 |
83289 |
0.09 |
chr1_89550370_89550583 | 9.39 |
Gm25180 |
predicted gene, 25180 |
12884 |
0.18 |
chr12_26680204_26680596 | 9.37 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
78091 |
0.1 |
chr14_78850676_78851236 | 9.33 |
Vwa8 |
von Willebrand factor A domain containing 8 |
1702 |
0.34 |
chr7_49088615_49088809 | 9.29 |
Gm32849 |
predicted gene, 32849 |
3629 |
0.24 |
chr18_40459021_40459343 | 9.28 |
Gm31019 |
predicted gene, 31019 |
19445 |
0.22 |
chr2_168248097_168248478 | 9.24 |
Gm14237 |
predicted gene 14237 |
5857 |
0.12 |
chr4_56288079_56288236 | 9.23 |
2310081O03Rik |
RIKEN cDNA 2310081O03 gene |
63636 |
0.13 |
chr2_35775823_35776075 | 9.22 |
Gm43760 |
predicted gene 43760 |
10070 |
0.2 |
chr5_122094478_122094843 | 9.18 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
6291 |
0.15 |
chr17_72275407_72275698 | 9.17 |
Gm19183 |
predicted gene, 19183 |
19294 |
0.28 |
chr8_54954036_54954355 | 9.16 |
Gpm6a |
glycoprotein m6a |
648 |
0.67 |
chr8_117935220_117935446 | 9.14 |
Gm10617 |
predicted gene 10617 |
133271 |
0.05 |
chr9_103689665_103690275 | 9.13 |
Tmem108 |
transmembrane protein 108 |
2837 |
0.32 |
chr4_87461244_87461952 | 9.11 |
Gm23154 |
predicted gene, 23154 |
29326 |
0.24 |
chr19_58822453_58822797 | 9.09 |
Hspa12a |
heat shock protein 12A |
504 |
0.77 |
chr1_94502083_94502408 | 9.08 |
Gm7895 |
predicted gene 7895 |
32358 |
0.23 |
chr9_86879639_86880662 | 9.06 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chr4_144936766_144937164 | 9.06 |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
18086 |
0.18 |
chr8_110711323_110711540 | 9.02 |
Mtss2 |
MTSS I-BAR domain containing 2 |
10045 |
0.16 |
chr1_118479349_118479550 | 9.01 |
Gm28466 |
predicted gene 28466 |
142 |
0.94 |
chr14_32073250_32073561 | 9.01 |
Dph3 |
diphthamine biosynthesis 3 |
11881 |
0.13 |
chrX_6926420_6926600 | 8.96 |
Dgkk |
diacylglycerol kinase kappa |
53026 |
0.15 |
chr7_48803519_48803712 | 8.96 |
Gm45041 |
predicted gene 45041 |
7313 |
0.16 |
chr8_9124477_9125000 | 8.95 |
4933430N04Rik |
RIKEN cDNA 4933430N04 gene |
7550 |
0.18 |
chr2_25460257_25461283 | 8.93 |
Paxx |
non-homologous end joining factor |
106 |
0.9 |
chr2_51753317_51753685 | 8.93 |
Gm13490 |
predicted gene 13490 |
21492 |
0.21 |
chr4_52043450_52043788 | 8.93 |
C630028M04Rik |
RIKEN cDNA C630028M04 gene |
7491 |
0.25 |
chr8_52571597_52571748 | 8.93 |
Gm45673 |
predicted gene 45673 |
16958 |
0.29 |
chr2_27195776_27196132 | 8.90 |
Sardh |
sarcosine dehydrogenase |
3694 |
0.16 |
chr8_105320451_105321442 | 8.89 |
Lrrc29 |
leucine rich repeat containing 29 |
5313 |
0.07 |
chr1_18181257_18181437 | 8.83 |
Crisp4 |
cysteine-rich secretory protein 4 |
35445 |
0.14 |
chr4_109676039_109677275 | 8.80 |
Faf1 |
Fas-associated factor 1 |
69 |
0.97 |
chr3_19566788_19567409 | 8.79 |
Gm23330 |
predicted gene, 23330 |
6845 |
0.18 |
chr10_19815499_19815650 | 8.75 |
Gm25256 |
predicted gene, 25256 |
32720 |
0.13 |
chr9_21424295_21424999 | 8.74 |
Dnm2 |
dynamin 2 |
261 |
0.85 |
chr14_118812628_118813057 | 8.68 |
n-R5s51 |
nuclear encoded rRNA 5S 51 |
14189 |
0.15 |
chr5_24861489_24861806 | 8.67 |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
10106 |
0.15 |
chr7_98148760_98149240 | 8.65 |
Omp |
olfactory marker protein |
3498 |
0.19 |
chr11_79069807_79070128 | 8.62 |
Ksr1 |
kinase suppressor of ras 1 |
4519 |
0.24 |
chr12_117744604_117744880 | 8.58 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
4147 |
0.25 |
chr4_72767006_72767179 | 8.54 |
Aldoart1 |
aldolase 1 A, retrogene 1 |
85540 |
0.1 |
chr13_11959591_11960207 | 8.54 |
Gm26956 |
predicted gene, 26956 |
20341 |
0.23 |
chr13_42656727_42657221 | 8.52 |
Phactr1 |
phosphatase and actin regulator 1 |
23649 |
0.2 |
chr1_135524592_135524802 | 8.50 |
Gm37333 |
predicted gene, 37333 |
641 |
0.67 |
chr9_120435940_120436126 | 8.47 |
Myrip |
myosin VIIA and Rab interacting protein |
8627 |
0.16 |
chr4_103636454_103636762 | 8.45 |
Dab1 |
disabled 1 |
16943 |
0.19 |
chr18_75130089_75130274 | 8.45 |
Dym |
dymeclin |
4756 |
0.22 |
chr1_157439951_157440671 | 8.42 |
Cryzl2 |
crystallin zeta like 2 |
18266 |
0.12 |
chr17_3442901_3443507 | 8.39 |
Tiam2 |
T cell lymphoma invasion and metastasis 2 |
3431 |
0.25 |
chr10_122025202_122025630 | 8.37 |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
21892 |
0.15 |
chr15_12365691_12366546 | 8.36 |
1810049J17Rik |
RIKEN cDNA 1810049J17 gene |
44219 |
0.12 |
chr13_84571404_84571594 | 8.33 |
Gm26913 |
predicted gene, 26913 |
119442 |
0.06 |
chr13_42671667_42671820 | 8.28 |
Phactr1 |
phosphatase and actin regulator 1 |
8880 |
0.24 |
chr2_118301975_118302126 | 8.28 |
1700054M17Rik |
RIKEN cDNA 1700054M17 gene |
2864 |
0.19 |
chr2_22029338_22029851 | 8.28 |
Gm13337 |
predicted gene 13337 |
38232 |
0.22 |
chr9_97826150_97826348 | 8.26 |
Gm37661 |
predicted gene, 37661 |
103906 |
0.07 |
chr1_18307545_18307752 | 8.25 |
Defb41 |
defensin beta 41 |
42510 |
0.14 |
chr19_37991486_37991747 | 8.25 |
Myof |
myoferlin |
24490 |
0.17 |
chr8_77988376_77988637 | 8.21 |
Gm29895 |
predicted gene, 29895 |
55504 |
0.15 |
chr3_115619961_115620260 | 8.20 |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
94962 |
0.07 |
chr1_41166164_41166401 | 8.20 |
4930448I06Rik |
RIKEN cDNA 4930448I06 gene |
14970 |
0.3 |
chr18_11145012_11145231 | 8.20 |
Gata6 |
GATA binding protein 6 |
86074 |
0.09 |
chr2_123813197_123813966 | 8.19 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
276388 |
0.02 |
chr14_22679666_22680655 | 8.16 |
Lrmda |
leucine rich melanocyte differentiation associated |
83647 |
0.09 |
chr12_31703971_31704189 | 8.13 |
Gpr22 |
G protein-coupled receptor 22 |
9846 |
0.16 |
chr5_113855669_113856215 | 8.10 |
Coro1c |
coronin, actin binding protein 1C |
2832 |
0.14 |
chr2_106652240_106652407 | 8.03 |
BB218582 |
expressed sequence BB218582 |
1959 |
0.39 |
chr11_25156710_25156955 | 8.02 |
4933427E13Rik |
RIKEN cDNA 4933427E13 gene |
75794 |
0.11 |
chr7_109114813_109115263 | 8.01 |
Gm44781 |
predicted gene 44781 |
27849 |
0.13 |
chr7_109849219_109849402 | 7.99 |
Scube2 |
signal peptide, CUB domain, EGF-like 2 |
8383 |
0.16 |
chr14_118001575_118002132 | 7.98 |
Dct |
dopachrome tautomerase |
25682 |
0.18 |
chr1_56928823_56929012 | 7.96 |
Satb2 |
special AT-rich sequence binding protein 2 |
40923 |
0.14 |
chr7_44473014_44473571 | 7.95 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
246 |
0.78 |
chr16_90921543_90921825 | 7.92 |
Gm49727 |
predicted gene, 49727 |
3848 |
0.12 |
chr2_52176708_52176879 | 7.90 |
Neb |
nebulin |
179 |
0.96 |
chr16_7099840_7100372 | 7.88 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
30260 |
0.27 |
chr10_96708565_96708738 | 7.87 |
Gm48507 |
predicted gene, 48507 |
3156 |
0.28 |
chr10_76586306_76586478 | 7.86 |
Ftcd |
formiminotransferase cyclodeaminase |
741 |
0.53 |
chr3_8866082_8866744 | 7.86 |
Gm15467 |
predicted gene 15467 |
14786 |
0.17 |
chr6_117251530_117251768 | 7.86 |
Rpl28-ps4 |
ribosomal protein L28, pseudogene 4 |
37583 |
0.17 |
chr6_50890370_50891401 | 7.84 |
G930045G22Rik |
RIKEN cDNA G930045G22 gene |
12808 |
0.17 |
chr11_104232039_104232621 | 7.84 |
Mapt |
microtubule-associated protein tau |
746 |
0.59 |
chr7_63956761_63957700 | 7.84 |
Gm45052 |
predicted gene 45052 |
5010 |
0.15 |
chr2_40982887_40983039 | 7.83 |
Gm13460 |
predicted gene 13460 |
15894 |
0.24 |
chr16_25255884_25256063 | 7.80 |
Tprg |
transformation related protein 63 regulated |
30844 |
0.25 |
chr9_15813389_15814034 | 7.77 |
Gm48711 |
predicted gene, 48711 |
9436 |
0.23 |
chr10_56980781_56980956 | 7.77 |
Gm36827 |
predicted gene, 36827 |
1364 |
0.54 |
chr16_14265466_14265813 | 7.76 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
25724 |
0.14 |
chr12_51117995_51118377 | 7.72 |
Gm7172 |
predicted gene 7172 |
16516 |
0.22 |
chr12_12225791_12225951 | 7.71 |
Fam49a |
family with sequence similarity 49, member A |
36268 |
0.2 |
chr10_46826710_46827035 | 7.68 |
Gm25650 |
predicted gene, 25650 |
11635 |
0.24 |
chr17_26892463_26892994 | 7.66 |
Gm17382 |
predicted gene, 17382 |
6526 |
0.09 |
chr5_124334425_124334781 | 7.65 |
2810006K23Rik |
RIKEN cDNA 2810006K23 gene |
6505 |
0.11 |
chr4_125545547_125545968 | 7.62 |
Mir692-2 |
microRNA 692-2 |
41008 |
0.15 |
chr18_48074131_48074928 | 7.62 |
Gm5237 |
predicted gene 5237 |
4507 |
0.28 |
chr15_81879860_81880417 | 7.61 |
Aco2 |
aconitase 2, mitochondrial |
7448 |
0.09 |
chr11_5795835_5796006 | 7.60 |
Dbnl |
drebrin-like |
7390 |
0.11 |
chr7_142094565_142096118 | 7.57 |
Dusp8 |
dual specificity phosphatase 8 |
69 |
0.83 |
chr3_69709128_69709981 | 7.57 |
Rpl32-ps |
ribosomal protein L32, pseudogene |
7839 |
0.17 |
chr16_43701779_43702078 | 7.55 |
Gm49735 |
predicted gene, 49735 |
8904 |
0.16 |
chr2_155610966_155611319 | 7.55 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
70 |
0.93 |
chr4_62619162_62620003 | 7.53 |
Rgs3 |
regulator of G-protein signaling 3 |
0 |
0.98 |
chr2_63982374_63982573 | 7.52 |
Fign |
fidgetin |
115515 |
0.07 |
chr8_72646405_72646797 | 7.51 |
Nwd1 |
NACHT and WD repeat domain containing 1 |
110 |
0.96 |
chr6_54759958_54760493 | 7.50 |
Znrf2 |
zinc and ring finger 2 |
56691 |
0.1 |
chr12_12274214_12274394 | 7.50 |
Fam49a |
family with sequence similarity 49, member A |
12115 |
0.28 |
chr19_53716555_53716887 | 7.47 |
Rbm20 |
RNA binding motif protein 20 |
39415 |
0.13 |
chr1_96346717_96347057 | 7.47 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr13_37602443_37602615 | 7.46 |
Gm47753 |
predicted gene, 47753 |
20258 |
0.1 |
chr4_147969452_147969633 | 7.43 |
Nppb |
natriuretic peptide type B |
16246 |
0.09 |
chr12_60821059_60821415 | 7.43 |
Gm38172 |
predicted gene, 38172 |
45355 |
0.18 |
chr16_73107664_73107993 | 7.42 |
4930500H12Rik |
RIKEN cDNA 4930500H12 gene |
8840 |
0.31 |
chr19_48333070_48333382 | 7.39 |
Gm23857 |
predicted gene, 23857 |
92581 |
0.08 |
chr3_139885937_139886924 | 7.38 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr2_178805310_178805611 | 7.38 |
Gm14314 |
predicted gene 14314 |
215673 |
0.02 |
chr7_19175722_19176163 | 7.36 |
Eml2 |
echinoderm microtubule associated protein like 2 |
479 |
0.59 |
chr9_78537160_78537490 | 7.35 |
Gm47430 |
predicted gene, 47430 |
16779 |
0.13 |
chr2_146502614_146503243 | 7.34 |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
8971 |
0.26 |
chr11_111215086_111215415 | 7.33 |
Gm11675 |
predicted gene 11675 |
60850 |
0.15 |
chr6_58862605_58862983 | 7.32 |
Herc3 |
hect domain and RLD 3 |
35 |
0.98 |
chr19_56774602_56774999 | 7.29 |
Gm6990 |
predicted pseudogene 6990 |
19454 |
0.14 |
chr18_58162064_58162437 | 7.28 |
Fbn2 |
fibrillin 2 |
38455 |
0.2 |
chr9_66295009_66295334 | 7.27 |
Dapk2 |
death-associated protein kinase 2 |
26797 |
0.18 |
chr1_132591364_132591989 | 7.25 |
Nfasc |
neurofascin |
4536 |
0.23 |
chr13_99676488_99676752 | 7.25 |
Gm24471 |
predicted gene, 24471 |
15909 |
0.21 |
chr2_97233061_97233235 | 7.24 |
Gm22313 |
predicted gene, 22313 |
4670 |
0.28 |
chr4_22269202_22269353 | 7.23 |
Gm11882 |
predicted gene 11882 |
6556 |
0.27 |
chr3_66480803_66481028 | 7.23 |
Gm17952 |
predicted gene, 17952 |
82636 |
0.1 |
chr3_88121464_88121953 | 7.22 |
Iqgap3 |
IQ motif containing GTPase activating protein 3 |
14592 |
0.1 |
chr7_64077658_64077809 | 7.22 |
Gm20670 |
predicted gene 20670 |
20131 |
0.15 |
chr17_5082966_5083455 | 7.22 |
Gm15599 |
predicted gene 15599 |
28900 |
0.2 |
chrX_59220669_59220853 | 7.21 |
Gm14890 |
predicted gene 14890 |
23798 |
0.19 |
chr17_10473990_10474553 | 7.21 |
A230009B12Rik |
RIKEN cDNA A230009B12 gene |
9434 |
0.24 |
chr11_65303923_65304117 | 7.21 |
Gm12295 |
predicted gene 12295 |
16187 |
0.22 |
chr14_64158929_64159285 | 7.19 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
42793 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.2 | 30.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
7.0 | 28.1 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
5.2 | 26.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
5.2 | 15.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
4.8 | 24.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
4.4 | 13.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
4.3 | 4.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
4.3 | 12.9 | GO:0021564 | vagus nerve development(GO:0021564) |
4.1 | 12.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
3.8 | 38.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
3.8 | 11.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
3.6 | 10.9 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.5 | 10.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.3 | 13.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
3.2 | 3.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
3.1 | 15.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
2.8 | 14.0 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
2.8 | 8.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
2.7 | 5.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
2.7 | 19.0 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
2.7 | 8.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.6 | 7.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
2.6 | 7.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.5 | 7.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.5 | 7.5 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
2.5 | 7.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.5 | 9.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.4 | 19.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
2.4 | 7.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.4 | 2.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.4 | 7.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.4 | 21.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
2.4 | 11.8 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
2.3 | 7.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.3 | 14.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.3 | 7.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.3 | 7.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.3 | 6.8 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
2.3 | 6.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
2.3 | 22.6 | GO:0030049 | muscle filament sliding(GO:0030049) |
2.2 | 4.5 | GO:0030421 | defecation(GO:0030421) |
2.2 | 6.6 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
2.2 | 2.2 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
2.2 | 15.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
2.2 | 13.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
2.2 | 6.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
2.1 | 6.4 | GO:0018343 | protein farnesylation(GO:0018343) |
2.1 | 6.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
2.1 | 10.5 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
2.1 | 4.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.1 | 4.2 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
2.1 | 6.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.1 | 6.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
2.1 | 8.2 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
2.1 | 6.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.0 | 2.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.0 | 6.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.0 | 10.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
2.0 | 24.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.0 | 8.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.0 | 10.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
2.0 | 6.0 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
2.0 | 8.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.0 | 9.9 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
2.0 | 7.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
2.0 | 5.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
2.0 | 7.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.9 | 17.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.9 | 7.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.9 | 5.7 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.9 | 7.7 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.9 | 5.7 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.9 | 1.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.9 | 5.6 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
1.8 | 11.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.8 | 11.0 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.8 | 14.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.8 | 5.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.8 | 1.8 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
1.8 | 5.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.8 | 1.8 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.8 | 3.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.8 | 7.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.8 | 1.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.8 | 10.7 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.8 | 5.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.8 | 1.8 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
1.8 | 5.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.8 | 15.9 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.8 | 15.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.7 | 1.7 | GO:1903273 | sodium ion export from cell(GO:0036376) regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
1.7 | 8.7 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.7 | 5.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.7 | 5.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.7 | 10.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.7 | 10.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.7 | 3.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.7 | 5.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.7 | 8.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.7 | 8.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.6 | 6.6 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.6 | 1.6 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.6 | 1.6 | GO:0030035 | microspike assembly(GO:0030035) |
1.6 | 1.6 | GO:0032762 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) |
1.6 | 4.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.6 | 4.9 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.6 | 6.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.6 | 4.9 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.6 | 6.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.6 | 1.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.6 | 4.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.6 | 3.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
1.6 | 6.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.6 | 1.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.6 | 4.7 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.6 | 4.7 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.6 | 3.1 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
1.6 | 4.7 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.6 | 9.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
1.5 | 17.0 | GO:0007614 | short-term memory(GO:0007614) |
1.5 | 4.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
1.5 | 7.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.5 | 4.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.5 | 4.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.5 | 20.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.5 | 1.5 | GO:0086068 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
1.5 | 3.0 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.5 | 5.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.5 | 7.3 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
1.5 | 2.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.5 | 2.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.5 | 2.9 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.5 | 1.5 | GO:0003192 | mitral valve formation(GO:0003192) |
1.5 | 4.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.4 | 4.3 | GO:0042938 | dipeptide transport(GO:0042938) |
1.4 | 1.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.4 | 4.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.4 | 2.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.4 | 2.8 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.4 | 8.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.4 | 2.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.4 | 4.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
1.4 | 5.6 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.4 | 4.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
1.4 | 4.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.4 | 7.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
1.4 | 1.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.4 | 9.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.4 | 6.9 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.4 | 4.2 | GO:0015705 | iodide transport(GO:0015705) |
1.4 | 2.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.4 | 2.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.4 | 9.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.4 | 9.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.4 | 2.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.4 | 2.7 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.4 | 4.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.4 | 1.4 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
1.4 | 5.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.3 | 4.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.3 | 12.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.3 | 4.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.3 | 6.7 | GO:0071625 | vocalization behavior(GO:0071625) |
1.3 | 4.0 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.3 | 3.9 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.3 | 14.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.3 | 2.6 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.3 | 7.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.3 | 6.5 | GO:0033227 | dsRNA transport(GO:0033227) |
1.3 | 1.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.3 | 2.6 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.3 | 2.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.3 | 1.3 | GO:0072718 | response to cisplatin(GO:0072718) |
1.3 | 3.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.3 | 1.3 | GO:0051036 | regulation of endosome size(GO:0051036) |
1.3 | 3.8 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
1.3 | 10.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.3 | 3.8 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.3 | 3.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.3 | 10.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.3 | 5.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.2 | 3.7 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.2 | 2.5 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
1.2 | 1.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.2 | 3.7 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.2 | 8.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.2 | 7.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.2 | 2.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.2 | 4.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.2 | 3.7 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.2 | 3.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.2 | 17.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.2 | 4.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.2 | 2.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.2 | 2.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.2 | 3.6 | GO:0061511 | centriole elongation(GO:0061511) |
1.2 | 8.5 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.2 | 2.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.2 | 3.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.2 | 3.6 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.2 | 16.9 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.2 | 1.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.2 | 3.6 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
1.2 | 1.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.2 | 6.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.2 | 2.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.2 | 3.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.2 | 1.2 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.2 | 1.2 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
1.2 | 2.4 | GO:0042891 | antibiotic transport(GO:0042891) |
1.2 | 4.7 | GO:0008228 | opsonization(GO:0008228) |
1.2 | 3.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.2 | 3.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.2 | 8.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.2 | 7.0 | GO:0015671 | oxygen transport(GO:0015671) |
1.2 | 1.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.2 | 5.8 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.2 | 1.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.2 | 1.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.2 | 3.5 | GO:0030242 | pexophagy(GO:0030242) |
1.2 | 1.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
1.2 | 2.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 8.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.1 | 12.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
1.1 | 3.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.1 | 4.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
1.1 | 8.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.1 | 3.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.1 | 2.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.1 | 5.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.1 | 2.2 | GO:0036258 | multivesicular body assembly(GO:0036258) |
1.1 | 1.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
1.1 | 3.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.1 | 3.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.1 | 2.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.1 | 8.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.1 | 3.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
1.1 | 2.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.1 | 8.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.1 | 9.7 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.1 | 5.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.1 | 1.1 | GO:0072197 | ureter morphogenesis(GO:0072197) |
1.1 | 3.2 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
1.1 | 3.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.1 | 3.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.1 | 2.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.1 | 3.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.1 | 5.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
1.1 | 2.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.1 | 5.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.1 | 7.4 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
1.1 | 3.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.0 | 1.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
1.0 | 4.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.0 | 3.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.0 | 2.1 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.0 | 5.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.0 | 1.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.0 | 4.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.0 | 4.1 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
1.0 | 6.1 | GO:0097264 | self proteolysis(GO:0097264) |
1.0 | 2.0 | GO:0035973 | aggrephagy(GO:0035973) |
1.0 | 3.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.0 | 21.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.0 | 30.5 | GO:0019228 | neuronal action potential(GO:0019228) |
1.0 | 5.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.0 | 7.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.0 | 2.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.0 | 1.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.0 | 3.0 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.0 | 4.0 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
1.0 | 3.0 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.0 | 1.0 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
1.0 | 3.0 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.0 | 5.0 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.0 | 10.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
1.0 | 2.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.0 | 3.0 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.0 | 8.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.0 | 6.0 | GO:0071435 | potassium ion export(GO:0071435) |
1.0 | 3.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.0 | 15.9 | GO:0060074 | synapse maturation(GO:0060074) |
1.0 | 1.0 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
1.0 | 2.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.0 | 2.0 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
1.0 | 2.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.0 | 3.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.0 | 9.8 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
1.0 | 1.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.0 | 5.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.0 | 7.8 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
1.0 | 3.9 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.0 | 2.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.0 | 1.0 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
1.0 | 1.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.0 | 4.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.0 | 1.0 | GO:0051182 | coenzyme transport(GO:0051182) |
1.0 | 4.8 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
1.0 | 4.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.0 | 7.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.0 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
1.0 | 2.9 | GO:0042117 | monocyte activation(GO:0042117) |
1.0 | 3.8 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.9 | 2.8 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.9 | 1.9 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.9 | 3.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.9 | 3.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.9 | 8.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.9 | 0.9 | GO:0090114 | vesicle coating(GO:0006901) COPII-coated vesicle budding(GO:0090114) |
0.9 | 2.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.9 | 2.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.9 | 22.3 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.9 | 6.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.9 | 2.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.9 | 4.6 | GO:0015808 | L-alanine transport(GO:0015808) |
0.9 | 6.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.9 | 12.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.9 | 5.5 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.9 | 0.9 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.9 | 2.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.9 | 0.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.9 | 2.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.9 | 2.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.9 | 1.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.9 | 6.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.9 | 2.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 | 1.8 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.9 | 6.3 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.9 | 2.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.9 | 2.7 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.9 | 1.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.9 | 3.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.9 | 3.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.9 | 7.1 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.9 | 5.3 | GO:0022605 | oogenesis stage(GO:0022605) |
0.9 | 2.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.9 | 0.9 | GO:0008334 | histone mRNA metabolic process(GO:0008334) histone mRNA catabolic process(GO:0071044) |
0.9 | 1.7 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.9 | 3.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.9 | 4.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.9 | 3.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.9 | 3.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.9 | 5.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.9 | 1.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.9 | 2.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.9 | 2.6 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.9 | 2.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.9 | 1.7 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.9 | 6.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.8 | 0.8 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.8 | 0.8 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.8 | 1.7 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.8 | 8.4 | GO:0008038 | neuron recognition(GO:0008038) |
0.8 | 6.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.8 | 5.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.8 | 2.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.8 | 1.7 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.8 | 4.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.8 | 2.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.8 | 2.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.8 | 4.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.8 | 0.8 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.8 | 0.8 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.8 | 5.7 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.8 | 3.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.8 | 8.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.8 | 4.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.8 | 0.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.8 | 2.4 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.8 | 1.6 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.8 | 13.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.8 | 4.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.8 | 3.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.8 | 5.7 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.8 | 2.4 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.8 | 0.8 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.8 | 0.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.8 | 3.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.8 | 1.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.8 | 8.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.8 | 9.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.8 | 1.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.8 | 3.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.8 | 15.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.8 | 7.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.8 | 1.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.8 | 0.8 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.8 | 0.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.8 | 0.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.8 | 1.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.8 | 3.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.8 | 1.6 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.8 | 0.8 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.8 | 2.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.8 | 3.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.8 | 8.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.8 | 2.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.8 | 2.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.8 | 3.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.8 | 3.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.8 | 1.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.8 | 3.0 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.8 | 3.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.8 | 1.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.8 | 3.8 | GO:0033572 | transferrin transport(GO:0033572) |
0.8 | 1.5 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.8 | 0.8 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.8 | 3.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.8 | 1.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.8 | 1.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 | 0.8 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.8 | 2.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.7 | 2.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.7 | 9.0 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.7 | 2.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.7 | 1.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.7 | 16.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.7 | 4.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.7 | 2.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 1.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.7 | 2.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.7 | 12.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 2.9 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.7 | 7.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.7 | 2.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.7 | 1.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.7 | 6.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.7 | 6.6 | GO:0015858 | nucleoside transport(GO:0015858) |
0.7 | 9.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.7 | 6.6 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.7 | 0.7 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.7 | 2.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.7 | 2.9 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.7 | 2.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.7 | 5.8 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.7 | 2.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.7 | 0.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.7 | 1.4 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.7 | 0.7 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.7 | 2.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.7 | 2.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.7 | 20.0 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.7 | 2.1 | GO:2000301 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.7 | 1.4 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.7 | 8.6 | GO:0042407 | cristae formation(GO:0042407) |
0.7 | 7.8 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.7 | 2.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.7 | 3.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.7 | 8.5 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.7 | 20.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.7 | 0.7 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.7 | 2.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.7 | 6.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.7 | 3.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 1.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.7 | 4.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.7 | 7.0 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.7 | 5.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.7 | 4.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.7 | 2.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.7 | 2.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.7 | 2.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.7 | 2.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.7 | 1.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.7 | 2.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 0.7 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.7 | 2.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 2.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.7 | 17.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.7 | 1.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.7 | 6.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.7 | 8.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 2.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.7 | 2.7 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.7 | 4.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.7 | 0.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.7 | 4.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.7 | 1.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.7 | 0.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.7 | 2.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.7 | 2.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 4.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.7 | 0.7 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.7 | 1.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.7 | 2.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.7 | 1.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.7 | 0.7 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.7 | 0.7 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.7 | 6.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.7 | 2.0 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.7 | 2.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.7 | 2.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.7 | 2.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.7 | 11.8 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.7 | 5.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.7 | 0.7 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.7 | 2.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 2.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 2.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.7 | 3.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 2.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.6 | 0.6 | GO:0071907 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
0.6 | 2.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.6 | 5.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.6 | 10.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.6 | 1.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.6 | 4.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.6 | 3.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.6 | 1.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.6 | 0.6 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.6 | 2.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.6 | 1.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.6 | 8.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.6 | 2.5 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.6 | 9.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.6 | 6.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.6 | 0.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.6 | 2.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.6 | 1.9 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.6 | 2.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.6 | 3.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.6 | 2.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 1.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.6 | 1.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 1.8 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.6 | 11.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.6 | 1.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 1.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.6 | 6.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.6 | 1.8 | GO:0061010 | gall bladder development(GO:0061010) |
0.6 | 1.2 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
0.6 | 1.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.6 | 0.6 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.6 | 1.8 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.6 | 1.8 | GO:0048478 | replication fork protection(GO:0048478) |
0.6 | 1.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 0.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.6 | 0.6 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.6 | 3.0 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.6 | 1.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.6 | 2.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.6 | 1.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.6 | 2.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.6 | 2.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.6 | 3.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.6 | 1.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.6 | 0.6 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.6 | 2.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.6 | 1.2 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.6 | 1.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.6 | 2.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.6 | 1.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.6 | 1.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 1.7 | GO:0015747 | urate transport(GO:0015747) |
0.6 | 1.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 5.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.6 | 1.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.6 | 2.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.6 | 2.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.6 | 3.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.6 | 8.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.6 | 1.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.6 | 1.1 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.6 | 6.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.6 | 2.3 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.6 | 0.6 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.6 | 1.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.6 | 4.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.6 | 0.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.6 | 1.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.6 | 2.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.6 | 2.8 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.6 | 0.6 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.6 | 3.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.6 | 1.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.6 | 2.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 3.9 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.6 | 2.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.6 | 1.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.6 | 0.6 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.5 | 4.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.5 | 1.6 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
0.5 | 2.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.5 | 1.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.5 | 3.8 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.5 | 1.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 1.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 1.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.5 | 6.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.5 | 1.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 0.5 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.5 | 12.8 | GO:0007041 | lysosomal transport(GO:0007041) |
0.5 | 1.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 2.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.5 | 1.6 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.5 | 15.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.5 | 0.5 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.5 | 1.6 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.5 | 2.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.5 | 1.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.5 | 3.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 5.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 1.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.5 | 7.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.5 | 1.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.5 | 2.1 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.5 | 1.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.5 | 1.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 20.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 2.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.5 | 2.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 2.0 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.5 | 1.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 3.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.5 | 30.5 | GO:0007612 | learning(GO:0007612) |
0.5 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 6.6 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.5 | 3.6 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.5 | 6.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.5 | 1.0 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.5 | 3.0 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.5 | 2.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 2.5 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.5 | 3.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 1.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.5 | 8.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.5 | 0.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.5 | 0.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.5 | 2.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.5 | 8.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 1.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.5 | 1.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.5 | 1.0 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.5 | 2.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 0.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.5 | 1.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.5 | 1.9 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.5 | 3.4 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.5 | 2.9 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.5 | 0.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.5 | 2.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.5 | 1.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.5 | 2.9 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.5 | 4.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.5 | 4.7 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 1.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 0.9 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.5 | 2.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 5.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 2.8 | GO:0060746 | parental behavior(GO:0060746) |
0.5 | 0.9 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.5 | 2.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 1.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 3.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.5 | 1.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.5 | 1.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.5 | 6.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 5.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 1.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.5 | 17.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.5 | 3.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.5 | 1.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.5 | 0.5 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.5 | 1.9 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 13.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.5 | 0.9 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.5 | 0.9 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.5 | 0.5 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.5 | 11.1 | GO:0006414 | translational elongation(GO:0006414) |
0.5 | 0.5 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.5 | 0.9 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.5 | 0.5 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.5 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.5 | 2.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 1.4 | GO:0061337 | cardiac conduction(GO:0061337) |
0.5 | 1.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 0.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.5 | 5.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.5 | 4.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.5 | 2.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.5 | 1.8 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.5 | 2.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 3.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.5 | 1.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 1.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 1.3 | GO:0060618 | nipple development(GO:0060618) |
0.4 | 1.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 1.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.4 | 1.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 1.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 11.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 2.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.4 | 2.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.4 | 0.4 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.4 | 1.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.9 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 0.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.4 | 3.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 3.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.4 | 0.4 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.4 | 1.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.4 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 0.9 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.4 | 0.9 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.4 | 1.3 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.4 | 0.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 2.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.4 | 2.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.4 | 4.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.4 | 3.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 1.7 | GO:0001964 | startle response(GO:0001964) |
0.4 | 1.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 1.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 0.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.4 | 3.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.4 | 1.3 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 2.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.4 | 4.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.4 | 6.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.4 | 2.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.4 | 11.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.4 | 0.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.4 | 2.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 1.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.4 | 1.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.4 | 0.4 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.4 | 2.1 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.4 | 5.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.4 | 0.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 1.7 | GO:0060872 | semicircular canal development(GO:0060872) |
0.4 | 0.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 4.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.4 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.4 | 1.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.4 | 1.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 0.4 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.4 | 0.4 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 1.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.4 | 1.2 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.4 | 1.2 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.4 | 4.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.4 | 0.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 0.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.4 | 15.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.4 | 1.6 | GO:0007435 | salivary gland morphogenesis(GO:0007435) |
0.4 | 2.0 | GO:0015791 | polyol transport(GO:0015791) |
0.4 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 1.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.4 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.4 | 4.0 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.4 | 0.8 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.4 | 1.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 0.4 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.4 | 2.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 1.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.4 | 1.6 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 1.6 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.4 | 1.6 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 0.4 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.4 | 30.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.4 | 2.0 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.4 | 1.6 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 1.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 1.2 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 2.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.4 | 0.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 0.8 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.4 | 0.4 | GO:0086004 | regulation of cardiac muscle cell contraction(GO:0086004) |
0.4 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.4 | 0.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 3.1 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.4 | 1.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 2.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 8.1 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.4 | 0.8 | GO:0044838 | cell quiescence(GO:0044838) |
0.4 | 3.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 6.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.4 | 0.4 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.4 | 0.8 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.4 | 2.3 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.4 | 0.8 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 0.4 | GO:0048382 | mesendoderm development(GO:0048382) |
0.4 | 0.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 2.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 2.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 2.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 1.5 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.4 | 1.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.4 | 4.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 1.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 1.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 1.5 | GO:0001881 | receptor recycling(GO:0001881) |
0.4 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 0.4 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.4 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.4 | 3.3 | GO:0048821 | erythrocyte development(GO:0048821) |
0.4 | 2.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.4 | 1.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 4.7 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 0.4 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.4 | 0.7 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 0.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 0.7 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 2.5 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.4 | 1.1 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.4 | 1.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.4 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 1.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.4 | 0.7 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 5.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.4 | 0.7 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.4 | 1.8 | GO:0051299 | centrosome separation(GO:0051299) |
0.4 | 1.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.4 | 1.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.4 | 5.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 1.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.4 | 2.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.4 | 1.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.4 | 3.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.4 | 4.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 0.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 1.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 7.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 4.9 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 2.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.3 | 2.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.3 | 1.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 0.7 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.3 | 0.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 2.8 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 1.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 1.0 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 2.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.3 | 6.9 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.3 | 2.7 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 26.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.3 | 0.3 | GO:0010421 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.3 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 0.3 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.3 | 0.7 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 2.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 2.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 8.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.3 | 8.4 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.3 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 2.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.3 | 2.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 6.0 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.3 | 6.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 2.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 0.7 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 1.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 0.3 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.3 | 3.9 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.3 | 4.9 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.3 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 2.3 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 2.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 9.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 1.0 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.3 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 0.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 2.3 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.3 | 1.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 0.3 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.3 | 1.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.6 | GO:1904667 | regulation of ubiquitin protein ligase activity(GO:1904666) negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.3 | 2.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.3 | 0.3 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.3 | 1.3 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.3 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.3 | 0.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 0.3 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.3 | 0.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 0.6 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 0.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 0.3 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.6 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.3 | 1.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 0.6 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.3 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.3 | 2.7 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.3 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.3 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 0.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 0.3 | GO:0014889 | muscle atrophy(GO:0014889) |
0.3 | 3.9 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.3 | 0.3 | GO:1902564 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) regulation of neutrophil activation(GO:1902563) negative regulation of neutrophil activation(GO:1902564) |
0.3 | 6.2 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.3 | 1.5 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.3 | 2.7 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.3 | 3.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 0.9 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.9 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 0.3 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.3 | 9.8 | GO:0007030 | Golgi organization(GO:0007030) |
0.3 | 0.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.3 | 7.7 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.3 | 3.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.3 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 2.9 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.3 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 1.7 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 1.1 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.3 | 2.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.3 | 1.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.3 | 0.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 0.6 | GO:0014075 | response to amine(GO:0014075) |
0.3 | 1.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.3 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 1.6 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 0.3 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.3 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 0.3 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.3 | 0.5 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.3 | 1.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.3 | 0.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.3 | 2.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 1.6 | GO:0080111 | DNA demethylation(GO:0080111) |
0.3 | 1.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 0.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.3 | 0.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 13.2 | GO:0044839 | cell cycle G2/M phase transition(GO:0044839) |
0.3 | 2.1 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 1.1 | GO:0002839 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.3 | 10.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.5 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 1.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 1.3 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.3 | 1.3 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.3 | 3.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.3 | 0.3 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.3 | 1.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.3 | 0.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 1.3 | GO:0007031 | peroxisome organization(GO:0007031) |
0.3 | 0.3 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.3 | 0.5 | GO:0070268 | cornification(GO:0070268) |
0.3 | 0.3 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.3 | 1.3 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 1.0 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.3 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 | 0.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.3 | 0.3 | GO:0086003 | cardiac muscle cell contraction(GO:0086003) |
0.3 | 1.0 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.2 | 24.4 | GO:0006457 | protein folding(GO:0006457) |
0.2 | 0.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.5 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 0.7 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.2 | 2.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 2.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 1.5 | GO:0008016 | regulation of heart contraction(GO:0008016) |
0.2 | 0.7 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.2 | 0.2 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.2 | 8.9 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 1.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 1.0 | GO:0042255 | ribosome assembly(GO:0042255) |
0.2 | 0.2 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.2 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 0.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.7 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 1.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.7 | GO:0009651 | response to salt stress(GO:0009651) |
0.2 | 0.7 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.2 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 1.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.2 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.2 | 0.7 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.2 | 0.4 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.4 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 2.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 6.6 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.2 | 0.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 0.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.2 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.7 | GO:0071025 | RNA surveillance(GO:0071025) |
0.2 | 1.5 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.2 | 0.4 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 4.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 4.7 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.2 | 1.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 1.3 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.6 | GO:0019243 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.6 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.2 | 0.2 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.2 | 1.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 2.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.6 | GO:0015879 | carnitine transport(GO:0015879) |
0.2 | 0.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.6 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.8 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.2 | 9.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.4 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.6 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 8.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 1.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.2 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.2 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.2 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.2 | 6.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 1.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 1.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.2 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.2 | 0.4 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.2 | 0.2 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 1.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.2 | 2.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 1.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 3.3 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 2.1 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.2 | 0.6 | GO:0002931 | response to ischemia(GO:0002931) |
0.2 | 0.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 1.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.2 | 3.8 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.2 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 3.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 1.5 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.6 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.2 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 2.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.2 | 3.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 1.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 4.5 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.2 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 1.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 1.4 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.2 | 0.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.2 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.2 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 1.0 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 0.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 0.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 1.0 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 1.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.7 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 0.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 0.3 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.2 | 0.8 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 0.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 0.3 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.5 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.6 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 0.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.6 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.2 | 2.3 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.2 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.2 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 1.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.1 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.1 | 0.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.8 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.7 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 2.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.9 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 2.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.8 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 1.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.6 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 1.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.8 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 3.4 | GO:0031497 | chromatin assembly(GO:0031497) |
0.1 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 1.3 | GO:1905037 | autophagosome organization(GO:1905037) |
0.1 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.1 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 1.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.6 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 0.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.3 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.4 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 1.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 2.5 | GO:0043038 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 4.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 1.3 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.1 | 4.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.7 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.1 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
0.1 | 1.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.5 | GO:0045780 | positive regulation of tissue remodeling(GO:0034105) positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.0 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.1 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0051231 | spindle elongation(GO:0051231) |
0.1 | 0.2 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.1 | 0.4 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 0.1 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.1 | 0.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.3 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 1.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.3 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.1 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.1 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.4 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 1.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 9.7 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.1 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 1.7 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 3.4 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.1 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.1 | 0.3 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.1 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 0.1 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.1 | 0.3 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 2.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.3 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
0.0 | 0.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 1.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 4.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.4 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.1 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.4 | GO:0060047 | heart contraction(GO:0060047) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.1 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.0 | 0.1 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:0022406 | membrane docking(GO:0022406) |
0.0 | 0.0 | GO:0090670 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.0 | 0.1 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.0 | 0.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.7 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.1 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 2.6 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 21.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
5.6 | 33.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
4.8 | 28.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
4.2 | 8.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
3.9 | 19.3 | GO:0097433 | dense body(GO:0097433) |
3.8 | 34.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
3.6 | 10.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
3.6 | 10.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
3.5 | 10.4 | GO:0097441 | basilar dendrite(GO:0097441) |
3.4 | 10.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.8 | 11.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.8 | 31.3 | GO:0043194 | axon initial segment(GO:0043194) |
2.3 | 7.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.3 | 6.8 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.2 | 8.9 | GO:0000322 | storage vacuole(GO:0000322) |
2.1 | 8.5 | GO:0044308 | axonal spine(GO:0044308) |
2.0 | 6.1 | GO:0097443 | sorting endosome(GO:0097443) |
1.9 | 5.7 | GO:0005955 | calcineurin complex(GO:0005955) |
1.9 | 13.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.9 | 13.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.9 | 3.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.8 | 14.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.8 | 9.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.8 | 5.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.7 | 3.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.7 | 46.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.7 | 22.1 | GO:0034704 | calcium channel complex(GO:0034704) |
1.7 | 1.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.7 | 10.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.6 | 6.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.6 | 11.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.6 | 3.1 | GO:0042585 | germinal vesicle(GO:0042585) |
1.6 | 9.3 | GO:0042629 | mast cell granule(GO:0042629) |
1.6 | 6.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.5 | 9.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.5 | 23.2 | GO:0097440 | apical dendrite(GO:0097440) |
1.5 | 15.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.5 | 4.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.5 | 4.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.5 | 9.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.5 | 13.3 | GO:0016342 | catenin complex(GO:0016342) |
1.5 | 7.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.4 | 5.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.4 | 4.2 | GO:1990130 | Iml1 complex(GO:1990130) |
1.4 | 1.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.4 | 4.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.4 | 4.1 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.4 | 4.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.4 | 2.7 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.4 | 9.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.4 | 4.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.3 | 5.4 | GO:0043083 | synaptic cleft(GO:0043083) |
1.3 | 9.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.3 | 34.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.3 | 2.6 | GO:0043219 | lateral loop(GO:0043219) |
1.3 | 11.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.3 | 1.3 | GO:0000938 | GARP complex(GO:0000938) |
1.3 | 17.7 | GO:0071565 | nBAF complex(GO:0071565) |
1.3 | 10.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.3 | 2.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.3 | 12.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.2 | 8.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.2 | 9.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
1.2 | 29.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.2 | 7.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.2 | 30.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.2 | 6.9 | GO:0070820 | tertiary granule(GO:0070820) |
1.2 | 3.5 | GO:0072534 | perineuronal net(GO:0072534) |
1.1 | 4.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.1 | 4.5 | GO:0016600 | flotillin complex(GO:0016600) |
1.1 | 1.1 | GO:0035838 | growing cell tip(GO:0035838) |
1.1 | 2.2 | GO:0032010 | phagolysosome(GO:0032010) |
1.1 | 14.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
1.1 | 4.5 | GO:0045298 | tubulin complex(GO:0045298) |
1.1 | 24.5 | GO:0036379 | myofilament(GO:0036379) |
1.1 | 5.5 | GO:0070695 | FHF complex(GO:0070695) |
1.1 | 7.5 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
1.1 | 6.4 | GO:0097470 | ribbon synapse(GO:0097470) |
1.1 | 4.3 | GO:0033269 | internode region of axon(GO:0033269) |
1.0 | 7.2 | GO:0031045 | dense core granule(GO:0031045) |
1.0 | 5.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.0 | 7.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 9.3 | GO:0005869 | dynactin complex(GO:0005869) |
1.0 | 11.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.0 | 29.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.0 | 15.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.0 | 2.0 | GO:0032437 | cuticular plate(GO:0032437) |
1.0 | 1.0 | GO:0044393 | microspike(GO:0044393) |
1.0 | 5.0 | GO:0032584 | growth cone membrane(GO:0032584) |
1.0 | 2.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.0 | 2.9 | GO:0048179 | activin receptor complex(GO:0048179) |
1.0 | 2.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.0 | 2.9 | GO:0044292 | dendrite terminus(GO:0044292) |
1.0 | 5.8 | GO:0071986 | Ragulator complex(GO:0071986) |
1.0 | 1.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.0 | 2.9 | GO:0097427 | microtubule bundle(GO:0097427) |
1.0 | 13.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.0 | 2.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.9 | 3.8 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 1.9 | GO:0005767 | secondary lysosome(GO:0005767) |
0.9 | 4.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.9 | 0.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.9 | 28.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.9 | 2.8 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.9 | 4.6 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.9 | 9.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.9 | 10.9 | GO:0032590 | dendrite membrane(GO:0032590) |
0.9 | 7.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.9 | 29.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.9 | 6.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.9 | 0.9 | GO:0097546 | ciliary base(GO:0097546) |
0.9 | 6.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.9 | 4.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.9 | 3.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.9 | 1.7 | GO:0071203 | WASH complex(GO:0071203) |
0.9 | 1.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.8 | 5.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.8 | 2.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.8 | 5.9 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.8 | 2.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.8 | 4.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.8 | 3.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.8 | 3.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.8 | 0.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.8 | 3.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 6.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.8 | 1.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.8 | 8.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.8 | 3.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.8 | 3.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.8 | 3.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.8 | 5.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 7.7 | GO:0043196 | varicosity(GO:0043196) |
0.8 | 51.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.7 | 3.0 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 14.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.7 | 4.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 3.7 | GO:0051286 | cell tip(GO:0051286) |
0.7 | 3.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.7 | 13.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.7 | 3.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.7 | 8.0 | GO:0016580 | Sin3 complex(GO:0016580) |
0.7 | 42.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 2.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.7 | 7.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.7 | 1.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 3.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.7 | 2.8 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.7 | 4.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.7 | 4.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.7 | 2.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.7 | 4.1 | GO:0071546 | pi-body(GO:0071546) |
0.7 | 5.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.7 | 2.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.7 | 6.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 1.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.7 | 10.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 2.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.7 | 2.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.7 | 23.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.7 | 2.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 2.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.7 | 38.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.7 | 2.0 | GO:0031417 | NatC complex(GO:0031417) |
0.7 | 5.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.6 | 2.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 3.8 | GO:0046930 | pore complex(GO:0046930) |
0.6 | 3.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.6 | 5.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.6 | 5.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 62.8 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.6 | 1.8 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.6 | 3.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.6 | 1.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.6 | 1.8 | GO:0000811 | GINS complex(GO:0000811) |
0.6 | 1.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.6 | 4.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 1.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.6 | 4.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.6 | 4.1 | GO:0000801 | central element(GO:0000801) |
0.6 | 3.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.6 | 7.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.6 | 4.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.6 | 3.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.6 | 11.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.6 | 3.4 | GO:0031415 | NatA complex(GO:0031415) |
0.6 | 6.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.6 | 1.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 2.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.6 | 2.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.6 | 2.8 | GO:0030118 | clathrin coat(GO:0030118) |
0.5 | 2.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 0.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 1.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 1.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.5 | 1.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 7.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 5.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 1.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.5 | 19.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.5 | 1.0 | GO:0071942 | XPC complex(GO:0071942) |
0.5 | 2.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 3.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 13.3 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 6.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.5 | 8.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.5 | 3.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.5 | 36.1 | GO:0030017 | sarcomere(GO:0030017) |
0.5 | 1.5 | GO:0030689 | Noc complex(GO:0030689) |
0.5 | 3.0 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.5 | 4.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 1.5 | GO:0005883 | neurofilament(GO:0005883) |
0.5 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 46.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 2.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 16.7 | GO:0005776 | autophagosome(GO:0005776) |
0.5 | 2.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 1.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.5 | 4.8 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.5 | 6.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 2.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 3.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.5 | 6.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 4.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.5 | 2.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 1.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 14.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.5 | 11.7 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.5 | 1.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 5.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.4 | 0.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.4 | 4.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.4 | 0.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 0.9 | GO:0044447 | axoneme part(GO:0044447) |
0.4 | 5.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.4 | 1.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.4 | 4.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.4 | 38.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.4 | 4.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.4 | 4.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 17.4 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.4 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 4.7 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 8.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 0.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 3.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 8.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.4 | 2.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.4 | 2.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.4 | 1.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 3.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 2.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 5.5 | GO:0030016 | myofibril(GO:0030016) |
0.4 | 5.8 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.4 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 2.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 8.8 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.4 | 3.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 1.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.4 | 1.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 1.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 2.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 14.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 2.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.4 | 4.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.4 | 2.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 1.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 10.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 0.4 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.4 | 0.7 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 10.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 0.7 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.4 | 16.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 24.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 3.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.3 | 8.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.3 | 2.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 15.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 1.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 3.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 1.0 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 20.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.3 | 3.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 8.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 0.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 4.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 45.7 | GO:0045202 | synapse(GO:0045202) |
0.3 | 1.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 6.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 12.7 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.3 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 0.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 9.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 0.3 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.3 | 0.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 1.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 17.3 | GO:0005814 | centriole(GO:0005814) |
0.3 | 2.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 2.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 3.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 4.8 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.3 | 6.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.3 | 0.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 1.8 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 1.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 0.6 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 1.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.3 | 1.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 3.8 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 0.3 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.3 | 1.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 12.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.3 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 25.4 | GO:0030424 | axon(GO:0030424) |
0.3 | 3.9 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.3 | 8.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 1.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 9.5 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 0.8 | GO:0030496 | midbody(GO:0030496) |
0.3 | 1.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 0.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 2.9 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 2.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 15.5 | GO:0043025 | neuronal cell body(GO:0043025) |
0.3 | 1.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 2.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 3.1 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 2.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 3.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 17.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 2.0 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.3 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 9.0 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 9.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 6.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 24.1 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 1.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 2.1 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 23.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 19.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 2.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 17.7 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 1.7 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 1.9 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 2.5 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.2 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.2 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 6.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 31.2 | GO:0043005 | neuron projection(GO:0043005) |
0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 7.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 17.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 7.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 6.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 2.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 5.3 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 0.3 | GO:0031082 | BLOC complex(GO:0031082) |
0.2 | 1.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 1.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 4.3 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 14.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 13.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.3 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 36.3 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.2 | 1.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 16.5 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 26.5 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 1.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 4.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 3.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 6.7 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 0.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 18.8 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.1 | 0.3 | GO:0030894 | replisome(GO:0030894) |
0.1 | 1.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 54.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 14.5 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.5 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.3 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 67.3 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.5 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.5 | 25.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
7.1 | 21.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
7.0 | 21.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
4.8 | 14.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
4.0 | 12.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
4.0 | 15.9 | GO:0031433 | telethonin binding(GO:0031433) |
3.9 | 31.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
3.7 | 14.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
3.5 | 3.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
3.4 | 10.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
3.1 | 3.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
3.0 | 8.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.9 | 8.6 | GO:0051373 | FATZ binding(GO:0051373) |
2.9 | 14.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.6 | 7.7 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
2.5 | 7.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.5 | 7.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.4 | 9.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.4 | 2.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.4 | 16.5 | GO:0031432 | titin binding(GO:0031432) |
2.3 | 6.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.3 | 9.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.2 | 8.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.2 | 2.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
2.1 | 10.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
2.1 | 6.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.1 | 6.3 | GO:0031013 | troponin I binding(GO:0031013) |
2.1 | 6.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.0 | 6.1 | GO:0051425 | PTB domain binding(GO:0051425) |
2.0 | 6.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.0 | 8.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.0 | 8.0 | GO:0042731 | PH domain binding(GO:0042731) |
2.0 | 8.0 | GO:0043515 | kinetochore binding(GO:0043515) |
2.0 | 9.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.0 | 9.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.9 | 5.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.9 | 5.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.9 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.9 | 5.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.9 | 5.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.9 | 13.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.9 | 11.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.9 | 7.5 | GO:0009374 | biotin binding(GO:0009374) |
1.9 | 16.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.9 | 3.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.9 | 5.6 | GO:0055100 | adiponectin binding(GO:0055100) |
1.9 | 7.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.8 | 7.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.8 | 16.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.8 | 9.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.8 | 1.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.8 | 7.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.7 | 8.6 | GO:0043559 | insulin binding(GO:0043559) |
1.7 | 16.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.7 | 6.7 | GO:0030911 | TPR domain binding(GO:0030911) |
1.6 | 13.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.6 | 4.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.6 | 1.6 | GO:0030172 | troponin C binding(GO:0030172) |
1.6 | 6.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.6 | 6.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.6 | 4.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.6 | 6.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.6 | 7.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.5 | 6.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.5 | 3.0 | GO:0070538 | oleic acid binding(GO:0070538) |
1.5 | 4.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.5 | 8.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.5 | 10.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.5 | 4.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.5 | 4.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.5 | 2.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.5 | 7.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.5 | 26.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
1.5 | 4.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.4 | 4.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.4 | 1.4 | GO:0002054 | nucleobase binding(GO:0002054) |
1.4 | 1.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.4 | 4.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.4 | 5.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.4 | 4.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.4 | 15.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.4 | 12.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.4 | 5.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.4 | 12.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.4 | 5.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.4 | 5.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.4 | 29.0 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.4 | 5.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.4 | 4.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.4 | 4.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.4 | 2.7 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
1.3 | 14.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.3 | 10.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.3 | 5.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.3 | 9.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.3 | 17.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.3 | 16.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.3 | 3.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.3 | 19.3 | GO:0030506 | ankyrin binding(GO:0030506) |
1.3 | 11.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.3 | 5.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.3 | 1.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.2 | 3.7 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.2 | 8.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.2 | 3.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.2 | 4.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.2 | 4.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.2 | 3.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.2 | 8.4 | GO:0003680 | AT DNA binding(GO:0003680) |
1.2 | 13.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.2 | 9.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.2 | 3.5 | GO:0050692 | DBD domain binding(GO:0050692) |
1.2 | 29.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.2 | 7.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.2 | 4.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.2 | 10.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.2 | 1.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.1 | 6.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.1 | 3.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.1 | 5.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.1 | 2.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.1 | 3.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.1 | 35.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.1 | 4.5 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.1 | 3.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.1 | 5.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.1 | 1.1 | GO:0038191 | neuropilin binding(GO:0038191) |
1.1 | 1.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.1 | 3.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.1 | 3.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.1 | 3.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.1 | 16.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.1 | 21.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.1 | 5.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.1 | 3.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.1 | 2.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.1 | 4.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.1 | 2.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.0 | 5.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.0 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
1.0 | 2.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.0 | 3.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.0 | 2.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.0 | 6.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.0 | 11.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.0 | 5.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.0 | 7.0 | GO:0034819 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.0 | 3.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.0 | 10.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.0 | 15.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.0 | 6.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.0 | 2.0 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.0 | 3.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.0 | 4.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.0 | 2.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.0 | 2.9 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.0 | 3.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.9 | 2.8 | GO:0004937 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.9 | 3.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.9 | 4.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.9 | 5.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.9 | 1.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.9 | 0.9 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.9 | 4.6 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.9 | 0.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.9 | 4.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.9 | 1.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.9 | 17.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.9 | 4.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.9 | 2.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 0.9 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.9 | 4.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.9 | 4.4 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.9 | 8.0 | GO:0070513 | death domain binding(GO:0070513) |
0.9 | 2.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 15.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.9 | 2.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.9 | 2.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.9 | 7.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.9 | 7.8 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.9 | 2.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.9 | 2.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.9 | 2.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.9 | 5.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.9 | 3.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.8 | 3.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.8 | 5.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.8 | 10.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 2.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.8 | 3.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.8 | 2.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.8 | 3.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.8 | 13.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.8 | 10.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.8 | 10.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.8 | 2.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.8 | 2.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.8 | 2.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.8 | 3.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.8 | 22.3 | GO:0045502 | dynein binding(GO:0045502) |
0.8 | 1.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.8 | 7.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.8 | 3.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.8 | 18.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.8 | 3.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.8 | 11.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 3.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.8 | 1.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.8 | 2.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 1.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.8 | 1.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.8 | 1.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.8 | 2.3 | GO:0032564 | dATP binding(GO:0032564) |
0.8 | 5.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.8 | 3.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.7 | 3.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.7 | 3.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 1.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.7 | 8.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.7 | 5.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 2.2 | GO:0034858 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.7 | 2.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.7 | 2.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.7 | 2.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.7 | 2.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.7 | 1.4 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.7 | 7.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.7 | 2.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.7 | 4.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.7 | 2.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.7 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 0.7 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.7 | 1.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.7 | 13.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.7 | 2.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 6.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.7 | 2.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.7 | 3.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.7 | 14.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 1.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.7 | 0.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.7 | 2.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.7 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 15.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.7 | 2.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.7 | 7.4 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.7 | 2.7 | GO:0071253 | connexin binding(GO:0071253) |
0.7 | 2.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 7.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.7 | 2.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.7 | 2.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.7 | 11.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.7 | 3.3 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 21.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.7 | 2.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.7 | 3.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.7 | 17.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.7 | 2.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.6 | 1.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.6 | 3.9 | GO:0035197 | siRNA binding(GO:0035197) |
0.6 | 3.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.6 | 1.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 3.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 3.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.6 | 6.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.6 | 1.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 18.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 2.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 1.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 1.9 | GO:0019961 | interferon binding(GO:0019961) |
0.6 | 2.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.6 | 3.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.6 | 3.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 1.2 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.6 | 4.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 6.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.6 | 2.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 1.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.6 | 6.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.6 | 1.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 3.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.6 | 2.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.6 | 12.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.6 | 1.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.6 | 1.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 1.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.6 | 0.6 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.6 | 8.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.6 | 1.8 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.6 | 1.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 1.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.6 | 4.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.6 | 3.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.6 | 1.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.6 | 12.6 | GO:0005537 | mannose binding(GO:0005537) |
0.6 | 1.2 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 3.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.6 | 1.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 4.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 1.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 1.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.6 | 4.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.6 | 1.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.6 | 7.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 1.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.6 | 8.1 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.6 | 0.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.6 | 1.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.6 | 2.9 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.6 | 2.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 2.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.6 | 3.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.6 | 1.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.6 | 2.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.6 | 3.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 24.7 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.6 | 0.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.6 | 1.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.6 | 5.0 | GO:0019825 | oxygen binding(GO:0019825) |
0.6 | 2.2 | GO:0015288 | porin activity(GO:0015288) |
0.6 | 5.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 1.1 | GO:0043176 | amine binding(GO:0043176) |
0.6 | 1.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 1.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 2.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.5 | 2.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.5 | 1.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 4.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.5 | 0.5 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.5 | 32.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.5 | 4.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 1.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 3.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 5.3 | GO:0019003 | GDP binding(GO:0019003) |
0.5 | 11.7 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.5 | 2.7 | GO:0016594 | glycine binding(GO:0016594) |
0.5 | 12.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 2.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 2.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 1.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 1.0 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.5 | 1.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.5 | 3.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.5 | 2.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.5 | 12.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.5 | 3.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.5 | 4.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.5 | 2.1 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 12.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 2.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.5 | 2.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 12.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.5 | 1.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 2.0 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.5 | 1.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 7.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 4.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.5 | 4.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 1.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 5.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.5 | 4.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.5 | 1.5 | GO:0089720 | caspase binding(GO:0089720) |
0.5 | 2.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 2.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 1.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.5 | 1.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 1.5 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.5 | 0.5 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.5 | 4.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 1.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.5 | 1.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 2.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 10.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.5 | 1.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 3.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 24.0 | GO:0002039 | p53 binding(GO:0002039) |
0.5 | 1.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 4.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 1.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.5 | 11.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 5.7 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.5 | 5.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 1.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 1.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.5 | 1.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 6.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.5 | 0.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.5 | 2.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 19.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.5 | 6.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.5 | 2.7 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.5 | 13.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.5 | 1.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 2.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 0.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 10.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 5.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.4 | 3.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 5.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 1.7 | GO:0034548 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 4.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.4 | 56.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.4 | 0.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 1.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 14.9 | GO:0005262 | calcium channel activity(GO:0005262) |
0.4 | 0.8 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.4 | 1.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 2.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 1.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 2.9 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.4 | 6.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 5.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 1.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 1.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 1.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 8.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 6.6 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.4 | 2.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 1.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 2.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 2.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.4 | 9.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 1.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.4 | 1.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.4 | 5.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 4.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.4 | 1.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 2.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.4 | 0.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 1.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.4 | 7.1 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 0.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 10.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.4 | 4.3 | GO:0044653 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.4 | 1.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 1.2 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 1.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 7.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.4 | 2.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.4 | 4.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.4 | 1.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 20.2 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.4 | 3.0 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.4 | 2.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 2.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 12.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.4 | 0.4 | GO:0017099 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.4 | 1.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.4 | 11.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 4.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 1.8 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 1.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 0.7 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 8.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 10.6 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.4 | 1.5 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 1.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.4 | 17.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.4 | 1.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.4 | 1.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 1.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 4.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 5.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.4 | 1.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 4.6 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.3 | 1.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 3.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 1.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.3 | 13.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.3 | 1.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 3.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 0.7 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.3 | 1.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.3 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 2.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 1.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 1.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 1.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 2.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 4.9 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.3 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 4.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 2.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 2.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) RNA polymerase core enzyme binding(GO:0043175) |
0.3 | 4.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 12.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.3 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 0.9 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 1.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 1.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 0.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 15.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.3 | 4.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 2.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 1.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 6.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 10.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 2.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 1.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 6.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.3 | 4.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.9 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 9.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 1.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 21.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.3 | 2.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 0.9 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 2.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 2.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.3 | 1.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 9.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.3 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 2.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 1.8 | GO:0010435 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 0.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 10.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.3 | 4.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 0.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.3 | 1.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 5.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 1.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 0.3 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 0.8 | GO:0030371 | translation repressor activity(GO:0030371) |
0.3 | 0.8 | GO:0032451 | demethylase activity(GO:0032451) |
0.3 | 8.0 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 1.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 3.2 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.2 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 16.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 1.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 2.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 1.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 2.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 1.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 1.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 5.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 1.9 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 1.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 32.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 2.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.2 | 12.2 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 2.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 1.8 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 2.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 1.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.9 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 1.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 1.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 11.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 1.9 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 0.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.2 | 2.7 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.2 | 1.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 2.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 10.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 8.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 1.2 | GO:0034912 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 1.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 0.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 1.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 1.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 1.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.2 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.2 | 3.8 | GO:0050661 | NADP binding(GO:0050661) |
0.2 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 4.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 4.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 3.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 25.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 10.5 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.2 | 2.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 3.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.5 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 13.9 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.2 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.8 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 0.2 | GO:0015927 | trehalase activity(GO:0015927) |
0.2 | 0.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 4.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 12.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 0.2 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 0.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 9.4 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 4.3 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 1.4 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 13.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 3.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 1.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 5.4 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 3.7 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 5.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.8 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 2.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 1.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 34.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 1.7 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 1.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 110.3 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 4.9 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 1.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 3.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 2.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 1.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 2.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 4.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 7.8 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 1.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 2.5 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 1.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.7 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.7 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 3.6 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 1.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.9 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.0 | GO:0060590 | ATPase activator activity(GO:0001671) ATPase regulator activity(GO:0060590) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 3.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.4 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 6.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.4 | 1.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.2 | 12.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.1 | 33.1 | PID REELIN PATHWAY | Reelin signaling pathway |
1.1 | 11.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.0 | 8.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.0 | 38.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.0 | 19.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.0 | 28.1 | PID INSULIN PATHWAY | Insulin Pathway |
1.0 | 35.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.0 | 23.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.0 | 6.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.0 | 1.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.9 | 26.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.9 | 8.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.9 | 12.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.9 | 2.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.8 | 24.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.8 | 22.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 2.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 12.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.7 | 13.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 18.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 4.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 7.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 10.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.6 | 5.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 21.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.6 | 10.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.6 | 17.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 6.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 7.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 2.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.5 | 9.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 2.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 7.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 3.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.5 | 6.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 11.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.5 | 5.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.5 | 1.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.5 | 3.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.5 | 0.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.4 | 12.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 0.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 5.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 12.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 7.3 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 6.2 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 4.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 1.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 4.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 6.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.4 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 1.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 1.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 4.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 4.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 8.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.3 | 3.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 2.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 4.7 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 2.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 0.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 6.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 2.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 3.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 1.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 2.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 0.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 4.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 3.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 1.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 1.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 3.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 1.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 6.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 4.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 0.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 5.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 5.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 3.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 1.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 2.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 2.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 5.4 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 3.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.5 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 36.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.3 | 49.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.1 | 2.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
2.1 | 45.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.8 | 29.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.7 | 26.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.6 | 21.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.6 | 4.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.4 | 17.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.4 | 23.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 8.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
1.3 | 5.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.2 | 14.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 29.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.1 | 13.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.1 | 44.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.1 | 10.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.1 | 26.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.1 | 11.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.0 | 11.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.0 | 22.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 2.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.0 | 9.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.0 | 8.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.0 | 20.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.0 | 15.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.9 | 8.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.9 | 37.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.9 | 2.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.9 | 18.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.9 | 5.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 22.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.9 | 2.7 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.9 | 20.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.9 | 8.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.8 | 11.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.8 | 5.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.8 | 14.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.8 | 9.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.8 | 6.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.8 | 5.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.8 | 7.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.7 | 7.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.7 | 6.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.7 | 1.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.7 | 13.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.7 | 4.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 4.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.6 | 12.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.6 | 3.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 5.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 5.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.6 | 3.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.6 | 6.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.6 | 10.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 1.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.6 | 4.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.6 | 7.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.6 | 17.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.6 | 4.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.6 | 3.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.5 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.5 | 21.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.5 | 1.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.5 | 7.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 8.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 2.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.5 | 10.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 10.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.5 | 9.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 5.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 3.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 1.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 6.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.5 | 5.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 6.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 8.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.5 | 16.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.5 | 6.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 13.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.5 | 7.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 9.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 2.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 0.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 2.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 3.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.5 | 4.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 26.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.4 | 4.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 2.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 8.8 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.4 | 2.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 5.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 13.0 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.4 | 3.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.4 | 0.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 1.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 17.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.4 | 5.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 5.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.4 | 2.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 2.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 3.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 5.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 2.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 3.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 3.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 2.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 17.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 5.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 1.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 1.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 15.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 7.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 15.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.3 | 6.5 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 3.7 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.3 | 3.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.3 | 3.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 3.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 13.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 16.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 5.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 9.9 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.3 | 1.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 4.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 5.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 2.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 10.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 2.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.3 | 0.5 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.3 | 3.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.3 | 4.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 2.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 3.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 0.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 3.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 1.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 1.9 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 5.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 1.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 1.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 5.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 3.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 3.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 0.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 2.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 1.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 1.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 0.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 4.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 3.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 1.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 3.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 0.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 3.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 4.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 17.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 2.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 3.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 2.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 4.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 3.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.7 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 7.8 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 1.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 2.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 4.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 3.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 2.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 1.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.2 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |